ECU
TMO icon

Egerton Capital (UK)’s Thermo Fisher Scientific TMO Stock Holding History

Egerton Capital (UK)’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-562,479
Closed -$293M – 27
2023
Q2 		$293M Buy
562,479
+455,728
+427% +$246M 3.03% 15
2023
Q1 		$61.5M Buy
+106,751
New +$60.2M 0.66% 23
2020
Q1 		– Sell
-934,456
Closed -$304M – 35
2019
Q4 		$304M Buy
934,456
+619,097
+196% +$188M 2.17% 20
2019
Q3 		$91.9M Sell
315,359
-24,634
-7% -$7.05M 0.66% 30
2019
Q2 		$99.8M Buy
+339,993
New +$93.6M 0.73% 28

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Egerton Capital (UK)'s TMO Position: Q3 2023 in Review

Egerton Capital (UK) sold out of Thermo Fisher Scientific (TMO) in Q3 2023, closing a stake of 562,479 shares — an estimated $293M sold.

Egerton Capital (UK) first reported a position in TMO in Q2 2019 and held it in 5 quarters. The position peaked at $304M in Q4 2019. 2,364 funds tracked by Wall St. Rank hold TMO as of Q3 2023.

  • Egerton Capital (UK) reported no remaining Thermo Fisher Scientific position as of Q3 2023 after selling out during the quarter.
  • Egerton Capital (UK) sold 562,479 Thermo Fisher Scientific shares in Q3 2023, an estimated $293M.
  • Egerton Capital (UK) first reported a position in Thermo Fisher Scientific in Q2 2019 and held it in 5 quarters.
  • Egerton Capital (UK)'s Thermo Fisher Scientific position peaked at $304M in Q4 2019.
  • 2,364 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2023.

Based on Egerton Capital (UK)'s 13F filing for Q3 2023, filed 13 Nov 2023.